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PURPOSE: To correlate postmortem histology from a MacTel type 2 patient with 
previously recorded clinical imaging data.  
DESIGN: Observational clinicopathological case report 
METHODS: The distribution of retinal blood vessels was used to map the location of 
serial wax sections in color fundus and optical coherence tomography (OCT) images.  
Fluorescent immunohistochemistry was used to visualize markers for Müller cells 
(vimentin and RLBP1), photoreceptors (LM-opsin, rhodopsin and COX2) and the 
outer limiting membrane (ZO-1 and occludin).     
MAIN OUTCOME MEASURES: Distribution of specific markers in 
immunohistochemistry on retinal sections through the fovea in relation to clinical 
data.  
RESULTS: The clinically recorded region of macular pigment loss in the macula 
correlated well with Müller cell depletion.  OCT data showed a loss of the 
photoreceptor inner segment/outer segment junction (IS/OS) in the central retina, 
which correlated well with rod loss but not with cone loss.  Markers for the outer 
limiting membrane were lost where Müller cells were lost.  
CONCLUSIONS: We have confirmed our previous finding of Müller cell loss in 
MacTel type 2 and have shown that the area of Müller cell loss matches the area of 
macular pigment depletion. In this patient the IS/OS junction seen by OCT was 




Macular telangiectasia (MacTel) type 2, also known as idiopathic juxtafoveolar 
telangiectasia type 2, is usually bilateral and can lead to legal blindness. The name 
of the disease is based on characteristic fluorescein angiographic changes in the 
macula, originally described by Gass.1  However, there are several additional 
disease signs, including loss of macular transparency, superficial white crystals, 
depletion of macular pigment and progressive foveal thinning.2-6 Furthermore, optical 
coherence tomography has identified hyporeflective spaces in the inner and outer 
retina in some patients.5-8  More advanced cases may also develop clumps of 
pigment cells in the retina and less commonly, subretinal neovascularisation.2 Visual 
symptoms are usually first noticed in the fifth to sixth decade and include reading 
difficulties and loss of visual acuity.9;10  During the early stages of MacTel type 2 
central scotopic function is reduced; more advanced cases usually develop dense 
scotopic and photopic scotomas in the perifovea.11-13  The cause of the disease is not 
known, and no treatment is known to prevent the progressive loss of central vision. 
 
We have previously reported a clinicopathologic analysis of a postmortem eye from a 
MacTel type 2 patient, finding a loss of Müller cells in the macula.14  We 
hypothesized that this specific loss of Müller cells may be a critical component of 
MacTel type 2 pathology but so far the anatomical basis of the specific losses in 
visual function is not clear.  We have now obtained postmortem eye samples from a 
second MacTel type 2 patient and correlated histopathological changes in 
photoreceptors with clinical data from this patient, including spectral domain optical 
coherence tomography (OCT), providing an anatomical rationale for the functional 






MATERIALS & METHODS  
 
Donor 
The donor was female and diagnosed with MacTel type 2 in 1992 at the age of 52.  
A glucose tolerance test (2007) showed a fasting plasma glucose of 6.5 mmol/L and 
a 2h plasma glucose of 10.4 mmol/L indicating impaired glucose tolerance but not 
diabetes mellitus.  Blood glucose levels were monitored since then and her fasting 
plasma glucose level was never over 8 mmol/L and HbA1C was below 7% (under 
diet control only).  This may be a possible explanation of why she did not develop 
diabetic retinopathy.  In 2007 the patient was diagnosed with scleroderma. According 
to her ophthalmologist she had retinal arteriolar abnormalities (premature arterial 
disease). 
 
Tissue processing  
Institutional review board (IRB)/ethic committee approval was obtained.  The time 
elapsed between death and fixation of the eyes in this study was 3.5 hours.  The left 
eye was fixed in 4% paraformaldehyde (PFA) for 64 hours and then kept in 1% PFA 
for 3 weeks.  Subsequently the anterior parts of the eye were removed and the eye 
was flattened (using four radial incisions) and photographed.  A region that included 
the optic disc and fovea was dissected from the eye and processed for wax 
embedding.  Because in our previously studied sample14 the retina split horizontally 
during embedding we used here a soft sponge to stabilize the tissue and apply 
gentle pressure during wax processing.  Once embedded, naso-temporal sections 
were cut at 6 µm and mounted onto Superfrost® plus slides (VWR).  Sections were 




Antigen retrieval was carried out by heating the slides to 125ºC in 90% glycerol 
(molecular grade) and 10% 0.01M citrate buffer pH6.0 for 20 minutes in a pressure 
cooker.  Sections were then briefly washed in water, incubated for 1 hour at room 
temperature in blocking buffer (1% BSA, 0.5% triton X-100 in PBS) and then in 
primary antibody (diluted 1:200 in blocking buffer) either at room temperature for 1 
hour or overnight at 4°C.  Primary antibodies used were: vimentin-Cy3 (Sigma, 
C9080), RLBP1 (AffinityBioReagents, MA1-813), GS (Chemicon, MAB302), 
rhodopsin (Chemicon, MAB5356), ML-opsin (Millipore, AB5405), ZO-1 (Invitrogen) 
and occludin (Invitrogen).  Sections were washed in washing buffer (0.1% tween20 in 
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PBS) and incubated for 1 hour at room temperature in secondary antibodies 
(Invitrogen, diluted 1:200 in blocking buffer).  Subsequently sections were washed in 
washing buffer, treated with Hoechst (10μg/ml in washing buffer) for 30 seconds, 
washed again and mounted in Moviol mounting medium (Sigma).  Images were 








The 61 year old female donor died in May 2011 from respiratory failure.  The patient 
suffered from scleroderma and end stage interstitial pulmonary fibrosis.  She was 
diagnosed with MacTel type 2 by one of the authors (APH) in 1992.  Later she was 
also diagnosed with type 2 diabetes (impaired glucose tolerance in 2007 and 
diabetes mellitus in 2009).  The diabetes was controlled with diet only and diabetic 
retinopathy was never diagnosed at any stage.  Increased prevalence of diabetes, 
but minimal diabetic retinopathy in MacTel type 2 patients has previously been 
reported.15-18  A fluorescein angiogram taken in March 2009 showed typical features 
of MacTel type 2 with telangiectatic vessels particularly in the temporal macula and 
diffuse staining in later images of both eyes (Fig. 1A, B). At the same visit optical 
coherence tomography (OCT) on the left eye showed hyporeflective spaces in the 
fovea (Fig.  1C) and discontinuity of the main hyper-reflective line in the 
photoreceptor layer (a line that is usually referred to as the inner/outer segment 
junction or IS/OS).  This line was missing in the fovea and the temporal macula 
(arrowheads in Fig. 1 C).  Photopic microperimetry (MP) showed a scotoma in the 
temporal macula (Fig. 1 D).  Similar findings were made in the right eye (not shown).  
One year later, in 2010 (one year before death) the donor’s last ophthalmic 
examination showed an almost symmetric loss of the IS/OS in the temporal and 
nasal macula of each eye (arrows in Fig. 1E).  However, the location of the scotoma 
was still predominantly temporal (Fig. 1F).  At that stage her visual acuity was OD 
20/125 and OS 20/125. Fundus color photographs showed localized clumping of 
pigmented cells in the temporal perifovea (Fig. 1G). Fundus autofluorescence 
showed hyper-autofluorescence due to a lack of masking of background normally 
caused by high levels of macular pigment in the central macula (Fig. 1H). 
 
Macular pigment 
Macroscopic examination of the fixed postmortem eye revealed loss of macular 
pigment in an oval area in the central retina (Fig. 2A), similar to our findings in the 
previously published postmortem case.14  This is hallmark feature of MacTel type 2 
confirms the diagnosis.3;4;19  Unfortunately, clinical data showing specifically the 
distribution of macular pigment, such as dual wavelength autofluorescence,4;19 was 
not available.  However, the color fundus image (Fig. 1G) contained sufficient color 
information to spatially localize the distribution of macular pigment loss.  To this end 
we isolated the blue channel in the color fundus image and enhanced the contrast 
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(Fig. 2B).  This revealed a bright central oval area that matched the shape and 
location of macular pigment distribution in the macroscopic image (Fig. 2A). The oval 
area also correlated well with clinical data obtained in other patients by confocal blue 
light imaging or dual wavelength macular pigment measurements.3;4;19  We therefore 
used the information in the blue channel from the fundus color image to plot the 
distribution of macular pigment in the color image (dotted circle in Fig. 2C).  
 
Matching of clinical data with histology  
In order to correlate postmortem histology with clinical data that was recorded before 
the donor’s death, we used the distribution of blood vessels to spatially match serial 
wax sections onto the color fundus image as previously described.14  This is 
illustrated in figure 2C where the nasal to temporal location of vessels (white dots in 
Fig. 2C) in 3 different sections (350, 405 and 485) correlated well with the color 
fundus image.  Based on this, we then used immunohistochemistry to correlate the 
distribution of specific cell populations with clinical imaging modalities. 
 
Müller cell loss 
In the first instance we visualized Müller cells with an antibody against vimentin on a 
section (404) through the fovea (Fig. 2D).  We have previously shown that in 
postmortem retina from healthy donors vimentin is expressed throughout the retina.14  
However, in the MacTel type 2 retina we found a dramatic loss of Müller cells in the 
central retina that matched the area of macular pigment loss (Fig. 2C, D), confirming 
our findings in the previous MacTel type 2 case study.14  This was illustrated by 
plotting the lateral distribution of Müller cells (horizontal red bars in Fig. 2D), which 
showed close correlation with macular pigment distribution (yellow arrows in Fig.  
2D).  Higher magnification of the vimentin immunohistochemistry also showed a 
good correlation between macular pigment loss (yellow arrows in Fig. 2C-F) and a 
loss of Müller cell processes in the inner and outer nuclear layers.  In the temporal 
macula the location of a large vessel (stars in Fig. 2C, F) confirmed the accuracy of 
the matching between the fundus image and the histology in this section. Additional 
sections from the superior and inferior macula showed smaller regions of Müller cell 
depletion that also matched well with the area of macular pigment loss (not shown).  
Labeling with an alternative marker for Müller cells, glutamine synthetase (GS, not 
shown) and retinaldehyde binding protein 1 (RLBP1, also known as CRALBP, Fig. 
4G) showed the same loss of staining in the central retina.  This was also the case in 
our previous MacTel 2 case, further suggesting a loss of cells rather than a 
downregulation of a specific marker.  Moreover, in our previous case the wax 
8 
 
embedding procedure caused horizontal splitting of the retina.  Here we observed the 
same horizontal splitting again (Fig. 2D-F), despite our efforts in this case to avoid 
this processing artifact by using a sponge to gently depress the tissue during wax 
embedding. Glial fibrillary acidic protein (GFAP) was only detected in retinal 
astrocytes (not shown), demonstrating the absence of reactive Müller cells, as in the 
previous case.14 
 
A lack of functional Müller cells may impact on inner retinal neurons.  In the previous 
case we have shown the presence of nuclei in the inner nuclear layer but at slightly 
reduced numbers.  Here, hematoxylin-eosin (H&E) staining also revealed the 
presence of numerous nuclei in the inner nuclear layer (Fig. 3, available at 
http://aaojournal.org) indicating that the majority of these neurons survive.  To further 
probe the state of inner retinal neurons we used an antibody against protein kinase C 
alpha (PRKCA, also known as PKC alpha), which is a marker for rod bipolar cells.20  
Similar to rods these cells become more sparse towards the fovea in normal retina.21  
In a central section (404) we found strong expression in the periphery and reduced 
staining towards the fovea (Fig. 4A-C, D, G, available at http://aaojournal.org).  
However, PRKCA positive cells could be found centrally to the boundaries of Müller 
cell and rod loss (Fig. 4 E, F, available at http://aaojournal.org), suggesting rod 
bipolar cells are not directly affected by either Müller cell or rod depletion.  
 
Cone photoreceptors  
Previous studies using OCT on MacTel type 2 patients have shown breaks in the 
IS/OS and linked those abnormalities to functional deficits.7;22  We therefore 
attempted to correlate the OCT data from our MacTel type 2 donor with tissue 
histology.  To this end we used the vessel shadows in the projection map of the OCT 
B-scans to match the color fundus image (Fig. 5A).  Furthermore, we traced breaks 
in the IS/OS line in each B-scan and mapped this onto the projection map (blue area 
in Fig. 5A).  The OCT scanning axis (green line in Fig. 5A) was not exactly in register 
with the direction of our histological sectioning (white line in Fig. 5A).  Nevertheless, 
the lateral distribution of the IS/OS break was similar in the central OCT B-scan axis 
(green line and black arrows in Fig. 5A, B) compared to the location of section 409 
(white line and blue arrows in Fig. 5A, C).   
 
In the first instance we aimed to correlate the IS/OS break (blue arrows in Fig. 5) with 
immunohistochemical staining of cone photoreceptors (in section 407).  An antibody 
against LM-opsin revealed strong staining of outer segments and weaker staining of 
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the entire photoreceptors (red in Fig. 5C-F).  Previous studies have linked the IS/OS 
signal with the ellipsoid region, 23-25 the mitochondria rich distal portion of the cone 
inner segment.26  We therefore used an antibody against cytochrome oxidase 2 
(COX2) to label mitochondria (green in Fig. 5C-F).  In the photoreceptor layer the 
COX2 stain revealed small oval structures adjacent to cone outer segments, 
presumably ellipsoids (Fig. 5D-F).  The lateral distribution of the COX2 positive 
ellipsoids and LM-opsin positive outer cone segments correlated well (horizontal 
green and red bars in Fig. 5C).  Surprisingly, this did not match with the IS/OS in the 
OCT scan (blue arrows in Fig. 5).  Particularly in the nasal macula the IS/OS was 
absent, whereas the immunohistochemistry showed largely intact cone 
photoreceptors in this area.  Nevertheless, two small patches of complete 
photoreceptor loss in the fovea (stars in Fig. 5F) corresponded well with the 
hyporeflective cavities seen in the OCT in the fovea (Fig. 5B).  H&E staining of a 
neighboring section (403) shows no structures inside those cavities (or cysts) 
suggesting that they are fluid filled in vivo.  Furthermore, a large area of cone 
depletion was observed in the temporal parafovea (arrowheads in Fig. 5E, F), which 
might explain the large, predominantly temporal scotoma recorded in the patient 
before death (Fig. 1D, F).     
 
Rod photoreceptors  
To further investigate cellular correlates to the IS/OS loss (Fig. 5A, B) we visualized 
rod photoreceptors with an antibody against rhodopsin (green in Fig. 5G-I) and their 
lateral distribution was plotted (green horizontal bars in Fig. 5G) in section 409.  This 
revealed a large rod free area in the central macula that corresponded well with the 
IS/OS loss seen in the OCT (blue arrows in Fig. 5G).  Higher magnification of the 
region where the rod stain is discontinued further demonstrated the close correlation 
with the IS/OS break (Fig. 5H, I).  As in the previous section (Fig. 5C-F) cones were 
stained for LM-opsin (red) and were only depleted in the temporal macula.   
 
Outer limiting membrane  
Since we found large areas of Müller cell and rod photoreceptor loss, we investigated 
the structure where these two cell types interact, the outer limiting membrane (OLM).  
The OLM is a planar array of adherens junctions between Müller cell processes and 
photoreceptors, which may influence the orientation and light guiding properties of 
photoreceptor outer segments and thereby possibly signals in OCT.  The OLM can 
be detected by OCT as a fine line internal to the IS/OS.23  In our patient this line 
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could be detected (Fig. 1E, 5B) up to the region where the IS/OS line was disrupted, 
but could not be identified further centrally. 
 
For immunohistochemistry we used an antibody against the tight junction protein 1, 
also known as zona occludens 1 (ZO-1), to visualize the OLM (red in Fig. 6A-F) and 
to relate its distribution to the OCT data and to Müller cells and rod distribution (in 
section 410).  In the peripheral retina ZO-1 was found in the OLM (white arrowheads 
in Fig. 6B, E).  Furthermore, we found staining in the outer plexiform layer (stars in 
Fig. 6B, C) and in blood vessels (e.g. next to yellow arrow in Fig. 6C).  The ZO-1 
labeling of the OLM was markedly reduced in the central macula (plotted as red 
horizontal bars in Fig. 6A).  In contrast, ZO-1 labeling of the outer plexiform layer and 
blood vessels was found throughout the retina (acting as an internal positive control).  
Double labeling against rhodopsin (green in Fig. 6A-F) showed that rods were 
present more centrally than the OLM (compare red and green horizontal bars in Fig. 
6A).  High magnification images (Fig. 6D, E) demonstrated this further.  Interestingly, 
the “OLM line” in the OCT (Fig. 1E, 5B) did not match the ZO-1 labeling and, like the 
IS/OS, correlated better with the area where rods had been depleted (green 
horizontal bar in Fig. 6A).  Near the fovea some residual ZO-1 staining could be 
detected in the location of the OLM (arrowhead in Fig. 6F).  However, this was much 
weaker than the staining of the OLM in the unaffected periphery. 
 
We also compared the distribution of the OLM markers with Müller cells.  To this end 
we studied an adjacent section (411) with an antibody against occludin (green in Fig. 
6G-L), which is also a tight junction protein and an alternative label for the OLM.  In 
addition we used an antibody against RLBP1 (also known as CRALBP, red in Fig. 
6G-L) to label Müller cells.  The area of Müller cell depletion (green horizontal bars in 
Fig. 6A) matched the area of macular pigment loss well (yellow arrows in Fig. 6), 
confirming our findings based on vimentin staining (Fig. 2). Furthermore, the area of 
Müller cell depletion correlated with the loss of the OLM marker occludin (red 
horizontal bar in Fig. 6G).  On the other hand, as shown for ZO-1 labeling, the 
occludin staining of the OLM did not have an obvious correlate in the OCT.  
Furthermore, as with ZO-1, there was very weak punctate staining in the location of 







In this study we have analyzed one postmortem eye from a single MacTel type 2 
case.  It is not straight forward to extrapolate findings from a single patient towards 
general disease mechanisms in MacTel type 2.  However, this limitation has in this 
study to some degree been compensated for by the precision of our postmortem 
analysis and by the matching of clinical data with histology.  We demonstrated here 
that this advanced histology approach of matching clinical data with 
immunohistochemistry can be useful to learn more about an uncommon disease, 
such as MacTel type 2, where it is difficult to obtain postmortem material. 
 
We have previously described Müller cell depletion in the macula of a MacTel type 2 
case.  Here we describe the same finding in a second case, suggesting that Müller 
cell depletion is a characteristic feature of MacTel type 2.  Two cases are not 
sufficient to make statistically significant statements.  Nevertheless, it can be argued 
that the occurrence of this very unusual phenotype (we are not aware of any other 
instances where Müller cell loss in the macula has been reported) in the two MacTel 
type 2 cases so far studied is most likely more than just a coincidence.    
 
It could be argued that Müller cells are not truly lost, but instead downregulate their 
usual markers and can no longer be detected by immunohistochemistry.  However, 
the fact that in this (and the previous) study three different Müller cell markers 
(vimentin, GS and RLBP1) disappeared from the macula makes this an unlikely 
scenario.  Also, even if such de-differentiated cells would be formed, they certainly 
could not be regarded as functional Müller cells.  Moreover, both samples (in the 
previous and the current study) had a tendency to split horizontally during 
embedding.  This suggests a loss of stability across the retinal thickness, which is 
consistent with a loss of functional Müller cells.    
 
The spatial correlation between macular pigment depletion and functional Müller cell 
loss demonstrated in our study is a further indication that Müller cell loss is a specific 
feature of MacTel type 2.  Indeed, because of the good correlation it is tempting to 
speculate that the two features are mechanistically linked.  For instance, it is possible 
that Müller cells are critically involved in the storage of macular pigment or in the 
metabolism that leads to the accumulation of macular pigment in the retina.  Macular 
pigment depletion could therefore be a direct indication of Müller cell death or 
dysfunction.  However, it is important to note that both MacTel type 2 patients that 
have been studied by postmortem histology so far, have had advanced disease.  
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Macular pigment loss occurs early during MacTel type 2 and it is not known yet 
whether this correlates with Müller cell loss also during the early stages of the 
disease.  Nevertheless, the pronounced loss of Müller cells found in two patients 
supports the emerging view that MacTel type 2 is not primarily a vascular disease, as 
its name suggests, but rather a degenerative condition affecting primarily glial cells 
and neurons.   
 
Because the IS/OS line is widely regarded to originate from the mitochondria rich 
ellipsoid region in the inner segments of cones and rods, it was surprising to find 
relatively normal appearing cones with clearly detectable mitochondria in the nasal 
macula.  In the previously described MacTel type 2 case no functional or OCT data 
was available that could be correlated with photoreceptor histology.  In contrast, the 
patient in this study had a dense, predominantly temporal scotoma and showed 
characteristic loss of the IS/OS line on OCT in the temporal and nasal macula.  
Importantly, the cones were histologically present in the nasal macula one year after 
the IS/OS line was found to be missing in OCT.   This discrepancy can therefore not 
be explained by disease progression.  Thus, it appears that the absence of the IS/OS 
line in MacTel type 2 should not be interpreted as a complete loss of photoreceptors 
but rather as the presence of conditions that degrade the IS/OS signal from cones.  
Such conditions may also be linked to reduced visual function as it has been shown 
in a study using 23 patients that the overall area of the IS/OS break in en face OCT 
imaging correlates with aggregate retinal sensitivity.27  
 
A feature that spatially correlated well with IS/OS loss was rod depletion, but whether 
there is a causal relationship is not clear.  Although cones and rods may both 
contribute to the IS/OS signal seen on OCT, it may also be the case that rod loss in 
MacTel type 2 directly abolishes the IS/OS line by an as yet unknown mechanism.  
For instance, the IS/OS line may depend on well aligned photoreceptors, and when 
rods are lost, cones may lose their normal alignment.  The IS/OS line does not stop 
in all MacTel type 2 patients as sharply as in our sample and sometimes a more 
gradual fading may occur.  This may relate to gradual rod loss.  In our patient the 
IS/OS was also missing in the fovea, where rods are usually not present.  This could 
suggest the presence of an upstream factor that affects both the IS/OS signal and 
rod survival.  Müller cell loss has to be considered a candidate for such an upstream 
factor, but the area of Müller cell loss was considerably larger than the area where 
the IS/OS and rods were lost.  Therefore the reason why the IS/OS line seen on OCT 




A further mismatch between clinical data and histology was the loss of the OLM.  Our 
analysis clearly demonstrated a spatial link between Müller cell loss and the loss of 
tight junction proteins in the OLM.  Since Müller cell processes are believed to be a 
critical component of the OLM this was expected.  However, it was surprising to find 
in the OCT scan a hyper-reflective line in areas where the histology demonstrated an 
absence of the OLM.  However, in the case of the OLM and IS/OS loss it is possible 
to explain the mismatch by disease progression because the OCT features may have 
spread further into the periphery in the final year before death.     
 
In summary, we present here in a patient with advanced MacTel type 2 two strong 
spatial correlations between clinical and histological data.  Firstly, we found that 
macular pigment depletion closely matched the loss of Müller cells.  Secondly, there 
was also a good match between IS/OS loss and rod depletion.  Because macular 
pigment depletion usually occurs before the IS/OS is lost in MacTel type 2,28 we may 
speculate that Müller cell dysfunction is an early and possibly causative feature of 






Figure 1.  Clinical data from the donor shows characteristic MacTel type 2 features.  
In fluorescein angiography (A, B) perifoveal blood vessels appear telangiectatic 
during early (A) and leaky during late (B) stage imaging. Optical coherence 
tomography (OCT) and microperimetry of the left eye in 2009 (C, D) and 2010 (E, F) 
shows a break in the inner segment/outer segment junction (IS/OS, arrowheads) and 
loss of function predominantly in the temporal macula.  Color fundus images (G) and 
autofluorescence (H) were also recorded. 
 
 
Figure 2.  Macular pigment and Müller cells are lost from an oval area in the macula.  
In the dissected globe (A) color photography showed loss of macular pigment in the 
fovea. An oval area in the macula appears less yellow than the rest of the retina.  
The contrast enhanced blue channel (B) from the color fundus photography (C) 
reveals an oval area that matches the macular pigment depletion in the dissected 
eye (arrows in A and B).  The oval area in B is plotted as a dotted yellow circle in C.  
The position of blood vessel (white dots in C) in serial wax sections (horizontal lines 
and numbers in C) is matched onto the color fundus photograph.  Anti-vimentin 
immunohistochemistry   (red stain in D-F) visualizes Müller cells and their lateral 
distribution is indicated by horizontal red bars in D.  White boxes in D relate to panels 
E and F. Stars in C and F indicate the same large blood vessel.  
 
 
Figures 3 and 4 are online only figures  
 
 
Figure 5.  Inner segment/outer segment junction (IS/OS) loss does not match cone 
but rod loss.  The IS/OS loss in OCT (blue area in A) is mapped onto the fundus 
image.  The dotted yellow circle outlines the area of macular pigment loss.  A central 
optical coherence tomography (OCT) scan (B and green line in A) is compared with 
a central section (C and white line A) that has been stained with antibodies against 
LM-opsin (red stain visualizing cones) and COX2 (green stain visualizing 
mitochondria) in C-F.  The IS/OS break (blue arrows) does not match with the 
distribution of opsin (red horizontal bars in C) and COX2 (green horizontal bar in C).  
In contrast, in a second central section stained with antibodies against LM-opsin (red 
stain visualizing cones) and rhodopsin (green stain visualizing rods) in G-I the IS/OS 
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break (blue arrows) correlates well with the distribution of rods (green horizontal bars 
in G).  White boxes in C relate to panels D-F and G to panels H and I. White 
arrowheads indicate cone depleted areas.  Stars indicate holes in the outer retina in 
the fovea. 
 
Figure 6.  Outer limiting membrane (OLM) loss does not match rod but Müller cell 
loss.  Stains on a central section show ZO-1 (in red visualizing the OLM) and 
rhodopsin (green, visualizing rods) in A-F.  The distribution of the OLM (red 
horizontal bars in A) does not match the distribution of rhodopsin (green horizontal 
bar in A).  In an adjacent section (G-L), stained to show occludin (in red visualizing 
the OLM) and RLBP1 (also known as CRALBP, in green visualizing Müller cells), the 
distribution of the OLM (red horizontal bars in G) correlates with the distribution of 
Müller cells (green horizontal bars in G).  IS/OS loss is indicated by blue arrows and 
macular pigment loss by yellow arrows.  White arrowheads indicate the OLM and 
stars indicate OLM-unrelated ZO-1 staining in the outer plexiform layer.  Green 
arrowheads indicate Müller cell bodies.  Boxes in A relate to panels B, C and F.  
Boxes in B and C related to panels D and F.  Boxes in G relate to panels H, I and L.  
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